10x Genomics, Inc. Operating Cash Flow
10x Genomics, Inc. (TXG) reported Operating Cash Flow of $43.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- 10x Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $16.97M, a 4.15% decline year-over-year.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $26.12M, a 23.96% decline year-over-year.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $40.78M.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $43.21M, a 99.69% increase year-over-year.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $136.05M, a 1941.57% increase from fiscal 2024.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $6.66M.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$15.20M.
- 10x Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$33.61M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $43.09M 10-Q · filed 2026-08-07 | $83.87M derived: sum of 3 quarters · filed 2026-08-07 | $127.08M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $26.12M 10-Q · filed 2026-05-08 | $66.90M derived: sum of 2 quarters · filed 2026-05-08 | $110.11M derived: sum of 3 quarters · filed 2026-05-08 | $127.82M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $40.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $83.99M derived: sum of 2 quarters · filed 2026-02-13 | $101.70M derived: sum of 3 quarters · filed 2026-08-07 | $136.05M 10-K · filed 2026-02-13 |
| 2025-09-30 | $43.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $60.92M derived: sum of 2 quarters · filed 2026-08-07 | $95.27M 10-Q · filed 2025-11-07 | $88.53M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $17.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $52.06M 10-Q · filed 2026-08-07 | $45.31M derived: sum of 3 quarters · filed 2026-08-07 | $66.95M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $34.35M 10-Q · filed 2026-05-08 | $27.60M derived: sum of 2 quarters · filed 2026-05-08 | $49.24M derived: sum of 3 quarters · filed 2026-05-08 | $56.74M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $14.89M derived: sum of 2 quarters · filed 2026-02-13 | $22.39M derived: sum of 3 quarters · filed 2026-02-13 | $6.66M 10-K · filed 2026-02-13 |
| 2024-09-30 | $21.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $29.14M derived: sum of 2 quarters · filed 2025-11-07 | $13.41M 10-Q · filed 2025-11-07 | $39.17M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$8.23M 10-Q · filed 2025-08-08 | $17.53M derived: sum of 3 quarters · filed 2026-02-13 | -$7.78M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$15.72M 10-Q · filed 2025-05-09 | $10.03M derived: sum of 2 quarters · filed 2026-02-13 | -$15.27M derived: sum of 3 quarters · filed 2026-02-13 | -$26.80M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $25.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $454.00K derived: sum of 2 quarters · filed 2026-02-13 | -$11.07M derived: sum of 3 quarters · filed 2026-02-13 | -$15.20M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$25.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$36.83M derived: sum of 2 quarters · filed 2024-10-29 | -$40.95M 10-Q · filed 2024-10-29 | -$27.23M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | -$11.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$15.65M 10-Q · filed 2024-08-08 | -$1.93M derived: sum of 3 quarters · filed 2025-02-13 | -$11.49M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$4.13M 10-Q · filed 2024-04-30 | $9.60M derived: sum of 2 quarters · filed 2025-02-13 | $34.00K derived: sum of 3 quarters · filed 2025-02-13 | -$16.93M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $13.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $4.16M derived: sum of 2 quarters · filed 2025-02-13 | -$12.80M derived: sum of 3 quarters · filed 2025-02-13 | -$33.61M 10-K · filed 2025-02-13 |
| 2022-09-30 | -$9.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$26.53M derived: sum of 2 quarters · filed 2023-11-03 | -$47.33M 10-Q · filed 2023-11-03 | -$41.52M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | -$16.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$37.77M 10-Q · filed 2023-08-04 | -$31.96M derived: sum of 3 quarters · filed 2024-02-15 | -$58.18M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | -$20.80M 10-Q · filed 2023-05-04 | -$15.00M derived: sum of 2 quarters · filed 2024-02-15 | -$41.21M derived: sum of 3 quarters · filed 2024-02-15 | -$38.09M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$20.41M derived: sum of 2 quarters · filed 2024-02-15 | -$17.29M derived: sum of 3 quarters · filed 2024-02-15 | -$21.37M 10-K · filed 2024-02-15 |
| 2021-09-30 | -$26.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$23.10M derived: sum of 2 quarters · filed 2022-11-03 | -$27.18M 10-Q · filed 2022-11-03 | -$157.35M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$962.00K 10-Q · filed 2022-08-09 | -$131.14M derived: sum of 3 quarters · filed 2023-02-16 | -$186.77M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$4.08M 10-Q · filed 2022-05-05 | -$134.26M derived: sum of 2 quarters · filed 2023-02-16 | -$189.89M derived: sum of 3 quarters · filed 2023-02-16 | -$219.40M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$130.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$185.80M derived: sum of 2 quarters · filed 2023-02-16 | -$215.32M derived: sum of 3 quarters · filed 2023-02-16 | -$217.90M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$55.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$85.15M derived: sum of 2 quarters · filed 2021-11-05 | -$87.72M 10-Q · filed 2021-11-05 | -$81.02M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$29.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$32.09M 10-Q · filed 2021-08-06 | -$25.39M derived: sum of 3 quarters · filed 2022-02-18 | -$10.87M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$2.58M 10-Q · filed 2021-05-07 | $4.12M derived: sum of 2 quarters · filed 2022-02-18 | $18.65M derived: sum of 3 quarters · filed 2022-02-18 | $22.73M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $21.23M derived: sum of 2 quarters · filed 2022-02-18 | $25.31M derived: sum of 3 quarters · filed 2022-02-18 | $34.63M 10-K · filed 2022-02-18 |
| 2019-09-30 | $14.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $18.61M derived: sum of 2 quarters · filed 2020-11-12 | $27.93M 10-Q · filed 2020-11-12 | -$23.07M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $13.40M 10-Q · filed 2020-08-12 | -$37.60M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2019-03-31 | $9.32M 10-Q · filed 2020-05-12 | -$41.68M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2018-12-31 | -$51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$76.41M 10-K · filed 2021-02-26 | ||
| 2018-09-30 | -$25.41M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | -$10.70M 10-K · filed 2020-02-27 |